Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bioxel Retains API Manufacturers to Scale-Up Cancer Ingredients | Contract Pharma

What are you searching for?

Sign in
Breaking News

Bioxel Retains API Manufacturers to Scale-Up Cancer Ingredients

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bioxel Pharma, Inc. has entered into two separate letters of intent with companies specialized in pharmaceutical API manufacturing. Under the terms of the agreements, these companies will perform the commercial scale-up of specific steps of Bioxel’s manufacturing process for semi-synthetic taxanes.

“These agreements represent a key milestone in the industrial scale-up of our technologies and the commercialization of our new taxane products,” said Pascal Delmas, president and chief executive officer of Bioxel Pharma. “We have aligned ourselves with industry leaders that have the facilities and pharmaceutical expertise to accelerate our development and bring our next products on stream.”

In the coming weeks, Bioxel expects to execute contract development and manufacturing agreements with both of these new partners and continue building its taxane product line.

In 2005 Bioxel filed two patents covering the synthetic conversion of 9-DHB to paclitaxel and docetaxel. 9-DHB is a side stream taxane that the company produced during the isolation and purification of natural paclitaxel, a product the company presently markets. These technologies allow for synthetic production of both paclitaxel and docetaxel, two of the world’s most widely used cancer therapy ingredients.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters